PNC Financial Services Group’s Entera Bio ENTX Stock Holding History

PNC Financial Services Group’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$795K	Hold	273,031	–	–	﹤0.01%	1537
2026 Q2	$483K	Buy	273,031 +263,031	+2,630%	+$329K	﹤0.01%	1811
2026 Q1	$11.1K	Hold	10,000	–	–	﹤0.01%	3910
2025 Q4	$19.4K	Hold	10,000	–	–	﹤0.01%	3675
2025 Q3	$19.2K	Hold	10,000	–	–	﹤0.01%	3664
2025 Q2	$19K	Hold	10,000	–	–	﹤0.01%	3596
2025 Q1	$17K	Hold	10,000	–	–	﹤0.01%	3618
2024 Q4	$21.2K	Sell	10,000 -3,000	-23%	-$5.6K	﹤0.01%	3506
2024 Q3	$24.7K	Hold	13,000	–	–	﹤0.01%	3408
2024 Q2	$23.9K	Hold	13,000	–	–	﹤0.01%	3390
2024 Q1	$21.7K	Hold	13,000	–	–	﹤0.01%	3412
2023 Q4	$7.8K	Hold	13,000	–	–	﹤0.01%	3818
2023 Q3	$9.42K	Buy	13,000 +3,000	+30%	+$2.21K	﹤0.01%	3778
2023 Q2	$8.43K	Hold	10,000	–	–	﹤0.01%	3950
2023 Q1	$11.6K	Hold	10,000	–	–	﹤0.01%	3749
2022 Q4	$7.3K	Hold	10,000	–	–	﹤0.01%	3878
2022 Q3	$10K	Hold	10,000	–	–	﹤0.01%	3764
2022 Q2	$13K	Hold	10,000	–	–	﹤0.01%	3682
2022 Q1	$29K	Buy	+10,000	New	+$24K	﹤0.01%	3392

Other funds holding ENTX

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

PNC Financial Services Group's ENTX Position: Q3 2026 in Review

PNC Financial Services Group held its Entera Bio (ENTX) position steady in Q3 2026 at 273,031 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

PNC Financial Services Group first reported a position in ENTX in Q1 2022 and has held it in 19 quarters since. 21 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

PNC Financial Services Group held 273,031 shares of Entera Bio worth $795K as of Q3 2026.
PNC Financial Services Group left its Entera Bio share count unchanged in Q3 2026.
Entera Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1537 holding.
PNC Financial Services Group first reported a position in Entera Bio in Q1 2022 and has held it in 19 quarters since.
21 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.